Cargando…
Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
BACKGROUND: Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-2...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143635/ https://www.ncbi.nlm.nih.gov/pubmed/34008449 http://dx.doi.org/10.1080/07853890.2021.1925149 |
_version_ | 1783696799018516480 |
---|---|
author | Ju, Yingnan Qiu, Lin Sun, Xikun Liu, Hengyu Gao, Wei |
author_facet | Ju, Yingnan Qiu, Lin Sun, Xikun Liu, Hengyu Gao, Wei |
author_sort | Ju, Yingnan |
collection | PubMed |
description | BACKGROUND: Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-26 in ARDS. METHODS: Thirty-two rats were anaesthetized and randomized into four groups: sham (S), ARDS (A), ARDS/Ac2-26 (AA), and ARDS/Ac2-26/BOC-2 (AAB) groups. Rats in the S group received saline for intratracheal instillation, while rats in the other three groups received endotoxin for intratracheal instillation, in order to prepare the ARDS and inject the saline, Ac2-26, and Ac2-26 combined with BOC-2. After 24 h, the PaO(2)/FiO(2) ratio was calculated. The lung tissue wet-to-dry weight ratio and the protein level in bronchoalveolar lavage fluid (BALF) were tested. Then, the cytokines in BALF and serum, and the inflammatory cells in BALF were investigated. Afterwards, the oxidative stress response and histological injury was evaluated. Subsequently, the epithelium was cultured and analyzed to estimate the effect of Ac2-26 on apoptosis. RESULTS: Compared to the S group, all indexes worsened in the A, AA, and AAB groups. Furthermore, compared to the S group, Ac2-26 significantly improved the lung injury and alveolar-capillary permeability, and inhibited the oxidative stress response. In addition, Ac2-26 reduced the local and systemic inflammation through the regulation of pro- and anti-inflammatory cytokines, and the decrease in inflammatory cells in BALF. Moreover, Ac2-26 inhibited the epithelium apoptosis induced by LPS through the modulation of apoptosis-regulated proteins. The protective effect of Ac2-26 on ARDS was partially reversed by the FPR inhibitor, BOC-2. CONCLUSION: Ac2-26 reduced the lung injury induced by LPS, promoted alveolar-capillary permeability, ameliorated the local and systemic inflammation, and inhibited the oxidative stress response and apoptosis. The protection of Ac2-26 on ARDS was mainly dependent on the FPR pathway. |
format | Online Article Text |
id | pubmed-8143635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-81436352021-06-07 Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway Ju, Yingnan Qiu, Lin Sun, Xikun Liu, Hengyu Gao, Wei Ann Med Pulmonary Medicine BACKGROUND: Acute respiratory distress syndrome (ARDS) is characterized by severe local and systemic inflammation. Ac2-26, an Annexin A1 Peptide, can reduce the lung injury induced by reperfusion via the inhibition of inflammation. The present study aims to evaluate the effect and mechanism of Ac2-26 in ARDS. METHODS: Thirty-two rats were anaesthetized and randomized into four groups: sham (S), ARDS (A), ARDS/Ac2-26 (AA), and ARDS/Ac2-26/BOC-2 (AAB) groups. Rats in the S group received saline for intratracheal instillation, while rats in the other three groups received endotoxin for intratracheal instillation, in order to prepare the ARDS and inject the saline, Ac2-26, and Ac2-26 combined with BOC-2. After 24 h, the PaO(2)/FiO(2) ratio was calculated. The lung tissue wet-to-dry weight ratio and the protein level in bronchoalveolar lavage fluid (BALF) were tested. Then, the cytokines in BALF and serum, and the inflammatory cells in BALF were investigated. Afterwards, the oxidative stress response and histological injury was evaluated. Subsequently, the epithelium was cultured and analyzed to estimate the effect of Ac2-26 on apoptosis. RESULTS: Compared to the S group, all indexes worsened in the A, AA, and AAB groups. Furthermore, compared to the S group, Ac2-26 significantly improved the lung injury and alveolar-capillary permeability, and inhibited the oxidative stress response. In addition, Ac2-26 reduced the local and systemic inflammation through the regulation of pro- and anti-inflammatory cytokines, and the decrease in inflammatory cells in BALF. Moreover, Ac2-26 inhibited the epithelium apoptosis induced by LPS through the modulation of apoptosis-regulated proteins. The protective effect of Ac2-26 on ARDS was partially reversed by the FPR inhibitor, BOC-2. CONCLUSION: Ac2-26 reduced the lung injury induced by LPS, promoted alveolar-capillary permeability, ameliorated the local and systemic inflammation, and inhibited the oxidative stress response and apoptosis. The protection of Ac2-26 on ARDS was mainly dependent on the FPR pathway. Taylor & Francis 2021-05-19 /pmc/articles/PMC8143635/ /pubmed/34008449 http://dx.doi.org/10.1080/07853890.2021.1925149 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pulmonary Medicine Ju, Yingnan Qiu, Lin Sun, Xikun Liu, Hengyu Gao, Wei Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
title | Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
title_full | Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
title_fullStr | Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
title_full_unstemmed | Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
title_short | Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
title_sort | ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway |
topic | Pulmonary Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143635/ https://www.ncbi.nlm.nih.gov/pubmed/34008449 http://dx.doi.org/10.1080/07853890.2021.1925149 |
work_keys_str_mv | AT juyingnan ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway AT qiulin ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway AT sunxikun ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway AT liuhengyu ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway AT gaowei ac226mitigatedacuterespiratorydistresssyndromeratsviaformylpeptidereceptorpathway |